Growth and endocrine function after chemotherapy and radiotherapy in childhood

European Journal of Cancer

Volumn 38, Issue 13, 2002, Pages 1748-1759

  Spoudeas, Helen A ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CORTICOTROPIN; GROWTH HORMONE; LIPID;

BODY GROWTH; BODY MASS; BONE DENSITY; BONE MINERALIZATION; BRAIN REGION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; ENDOCRINE DISEASE; ENDOCRINE FUNCTION; ENERGY EXPENDITURE; FERTILITY; FOLLOW UP; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPERINSULINEMIA; LIFESTYLE; MITOGENICITY; MORBIDITY; OBESITY; PATHOPHYSIOLOGY; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION RESPONSE; REVIEW; SKULL IRRADIATION; SOCIAL ADAPTATION; TREATMENT PLANNING; ARTICLE; CENTRAL NERVOUS SYSTEM TUMOR; CHEMICALLY INDUCED DISORDER; CHILD; GROWTH DISORDER; RADIOTHERAPY; SURVIVOR;

ANTINEOPLASTIC AGENTS; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CRANIAL IRRADIATION; ENDOCRINE SYSTEM DISEASES; FOLLOW-UP STUDIES; GROWTH DISORDERS; GROWTH HORMONE; HUMANS; QUALITY OF LIFE; RADIOTHERAPY; SURVIVORS;

EID: 0036343032     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(02)00169-7     Document Type: Article

References (91)

1. Acute neurotoxicity in children with B-precursor acute lymphoid leukaemia: An association with intermediate-dose intravenous methotrexate and intrathecal triple therapy - A pediatric oncology group study
2. Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation; A pediatric oncology group study
3. Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: A children's cancer study group study
4. A prospective study of the development of growth hormone deficiency in children given cranial irradiation, and its relation to statural growth
5. Growth and growth hormone secretion in children following treatment of brain tumours with radiotherapy
6. Hypopituitarism following external radiotherapy for pituitary tumours in adults
7. Evolution of growth hormone (GH) neurosecretory disturbance after cranial irradiation for childhood brain tumours; A prospective study
8. Thyroid dysfuncton after radiotherapy and chemotherapy of brain tumours
9. Gonadal dysfunction after treatment of intracranial tumours
10. Uncritical use of bone mineral density in absorptiometry may lead to size-related artefacts in the identification of bone mineral determinants
11. Growth hormone neurosecretory dysfunction: A treatable cause of short stature
12. Short-term endocrine consequences of total body irradiation and bone marrow transplantation in children treated for leukaemia
13. Neurotransmitter control of growth hormone secretion in children after cranial radiation therapy
14. The effect of radiation at the tissue level
15. The influence of radiation on fertility in man
16. Incidence of second primary tumours among childhood cancer survivors
17. Dose dependency of time of onset of radiation-induced growth hormone deficiency
18. Hypothalamic- pituitary dysfunction after radiation for brain tumors
19. The effects of adjuvant chemotherapy on growth in children with medulloblastoma
20. Radiosensitivity of hypothalamo-pituitary (HP) function in the rat is time and dose dependent
21. The molecular basis for developmental disorders of the pituitary gland in man
22. Delayed onset of hypopituitarism: Sequelae of therapeutic irradiation of central nervous system, eye, and middle ear tumours
23. Growth hormone deficiency after treatment of acute leukaemia in children
24. The relationship between the growth hormone and insulin-like growth factor axis in long-term survivors of childhood brain tumours
25. The effect of cranial irradiation for tumours distal to the pituitary on ACTH secretion
26. A novel variant of growth hormone (GH) insufficiently following low dose cranial irradiation
27. Endocrine and reproductive dysfunction following fractionated total body irradiation in adults
28. Endocrine deficit after fractionated total body irradiation
29. Growth hormone status in adults treated for acute lymphoblastic leukaemia in childhood
30. Reduced hypothalamic blood flow after radiation treatment of nasopharyngeal cancer: SPECT studies in 34 patients
31. Effects of cranial radiation on hypothalamic- adenohypophyseal function: Abnormal growth hormone secretory dynamics
32. Differential effects of cranial irradiation on growth hormone responses to arginine and insulin infusion
33. Effect of growth hormone-releasing factor on growth hormone release in children with radiation-induced growth hormone deficiency
34. Potential for fertility with replacement of hypothalamic gonadotropin-releasing hormone in long term female survivors of cranial tumours
35. Treatment of radiation-induced growth hormone deficiency with growth hormone-releasing hormone
36. Responsiveness of irradiated rat anterior pituitary cells to hypothalamic releasing hormones is restored by treatment with growth hormone
37. A longitudinal study of growth and growth hormone secretion in children during treatment for acute lymphoblastic leukaemia
38. Suppressed spontaneous secretion of growth hormone in girls after treatment for acute lymphoblastic leukaemia
39. Nonparallel changes of growth hormone (GH) and insulin-like growth factor-1, insulin-like growth factor binding protein-3, and GH-binding protein, after craniospinal irradiation and chemotherapy
40. Growth in children treated for acute lymphoblastic leukaemia
41. Growth failure and growth-hormone deficiency after treatment for acute lymphoblastic leukaemia
42. Drop SLS. Long-term effects of treatment for acute lymphoblastic leukaemia with and without cranial irradiation on growth and puberty: A comparative study
43. Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukaemia
44. Growth in children after bone marrow transplantation: Busulfan plus cyclophosphamide versus cyclophosphamide plus total body irradiation
45. Chemotherapeutic agents used in the treatment of childhood malignancies have direct effects on growth plate chondrocyte proliferation
46. Glucocorticoid pre-treatment reduces the cytotoxic effects of a variety of DNA-damaging agents on rat tibial growth-plate chondrocytes in vitro
47. Abnormal growth patterns and adult short stature in 115 long-term survivors of childhood leukaemia
48. Disproportionate short stature after cranial irradiation and combination chemotherapy for leukaemia
49. Growth retardation in children after megavoltage irradiation of the spine
50. Effect of spinal irradiation on growth
51. Hyperfractionation decreases the deleterious effects of conventional radiation fractionation on vertebral growth in animals
52. Growth and development following marrow transplantation for leukaemia
53. Growth in children following irradiation for bone marrow transplantation
54. Growth hormone treatment of growth failure secondary to total body irradiation and bone marrow transplantation
55. Growth and growth hormone secretion after bone marrow transplantation
56. Growth after total body irradiation (TBI): Response to growth hormone (GH) therapy
57. Cranial irradiation and early puberty
58. Ovarian function following chemotherapy for childhood brain tumours
59. Testicular damage after chemotherapy for childhood brain tumors
60. Menarche in a cohort of 188 1ong-term survivors of acute lymphoblastic leukaemia
61. Fertility and progeny
62. Pregnancies following high dose cyclophosphamide with or without high-dose busulphan or total body irradiation and bone marrow transplantation
63. Patterns of obesity in boys and girls after treatment of acute lymphoblastic leukaemia
64. Effects of growth hormone on components of the leptin system
65. Hypothalamic, pituitary and thyroid dysfunction after radiotherapy to the head and neck
66. Serial thyroid function measurements in children with Hodgkin disease
67. Thyroid function in pediatric patients after neck irradiation for Hodgkin disease
68. An evaluation of long-term survival and treatment complications in children with Hodgkin's disease
69. Cyclical combination chemotherapy and thyroid function in patients with advanced Hodgkin's disease
70. Thyroid function after treatment of brain tumors in children
71. The impact of marrow transplant preparative regimens on subsequent growth and development
72. Thyroid dysfunction following bone marrow transplantation: Long term follow-up of 80 pediatric patients
73. Adrenocorticotrophin and cortisol secretion in children after low dose cranial irradiation
74. Adrenocorticotrophin (ACTH) deficiency undetected by standard dynamic tests of the hypothalamic-pituitary-adrenal axis
75. The use of low doses of ACTH in the investigation of adrenal function in man
76. Osteoporosis after cranial irradiation for acute lymphoblastic leukaemia
77. Alterations in bone turnover and impaired development of bone mineral density in newly diagnosed children with cancer: A 1-year prospective study
78. Growth in children with craniopharyngioma following surgery
79. Truncal vagotomy in hypothalamic obesity
80. Hypothalamic obesity caused by cranial insult in children: Altered glucose and insulin dynamics and reversal by a somatostatin agonist
81. Reduced energy expenditure in pre-obese children treated for acute lymphoblastic leukemia
82. The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: Evidence for growth hormone modulation of extrarenal beta-hydroxysteroid dehydrogenase activity
83. The effect of growth hormone and IGF-1 on clonogenic growth of haematopoietic cells in leukaemic patients during active disease and during remission - A preliminary report
84. Increased chromosome fragility in lymphocytes of short normal children treated with recombinant human growth hormone
85. Risk of leukaemia after treatment with pituitary growth hormone
86. Growth hormone treatment of children with brain tumours and risk of tumour recurrence
87. Leukaemia and growth hormone
88. Lymphocyte subsets and natural-killer activity in growth hormone deficiency
89. Growth hormone inhibits tumor metastasis